ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Swapping IV for a pill? early test of oral arsenic for blood cancer
Disease control CompletedThis early-stage study tested a new oral liquid form of the drug arsenic trioxide in 12 patients with a specific type of leukemia (APL). The main goal was to see how the body absorbs the oral drug compared to the standard IV version, and whether taking it with food or calcium cha…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Harvard tests AI as Cancer-Detecting partner for doctors
Diagnosis CompletedThis study tested whether artificial intelligence (AI) could help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Doctors reviewed bone marrow samples with and without AI assistance to see if the technology improved thei…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Apr 02, 2026 14:56 UTC